Litcius/Paper detail

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions

Sara Donzelli, Mario Cioce, Andrea Sacconi, Francesca Zanconato, Theodora Daralioti, Frauke Goeman, Giulia Orlandi, Simona Di Martino, Vito Michele Fazio, Gabriele Alessandrini, Stefano Telera, Mariantonia Carosi, Gennaro Ciliberto, Claudio Botti, Sabrina Strano, Stefano Piccolo, Giovanni Blandino

2022Molecular Cancer24 citationsDOIOpen Access PDF

Topics & Concepts

OrganoidMetastatic breast cancerBiologyBreast cancerOncologyCancerMutantInternal medicineCancer researchMedicineGeneBiochemistryGeneticsAdvanced Breast Cancer TherapiesPI3K/AKT/mTOR signaling in cancerCancer Cells and Metastasis
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions | Litcius